Assenagon Asset Management S.A. Pmv Pharmaceuticals, Inc. Transaction History
Assenagon Asset Management S.A.
- $65.1 Billion
- Q3 2025
A detailed history of Assenagon Asset Management S.A. transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 123,092 shares of PMVP stock, worth $172,328. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,092
Previous 263,059
53.21%
Holding current value
$172,328
Previous $278,000
38.13%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding PMVP
# of Institutions
61Shares Held
37.4MCall Options Held
100Put Options Held
0-
Orbimed Advisors LLC San Diego, CA6.48MShares$9.07 Million0.25% of portfolio
-
Bml Capital Management, LLC Zionsville, IN5MShares$7 Million4.01% of portfolio
-
Sio Capital Management, LLC New York, NY3.74MShares$5.23 Million1.89% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.19MShares$4.46 Million0.07% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.68 Million0.92% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $63.9M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...